Dr. Sowmya Deshpande disposed of a significant portion of her holding in Family Care Hospitals Limited, selling 7,52,871 equity shares through the open market. The transactions occurred over three trading days, from August 12, 2026, to August 14, 2026.

The sale reduced Dr. Deshpande’s stake in the healthcare company from 4.26% to 2.82% of the total voting capital. Prior to the disposal, she held 23,03,129 shares carrying voting rights. Following the transaction, her remaining holding stands at 15,50,258 shares.

Transaction Details

The disclosure was made pursuant to Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Dr. Deshpande is not classified as part of the promoter or promoter group of the target company.

Family Care Hospitals Limited has an equity share capital of ₹54,01,47,740, comprising 5,40,14,774 shares with a face value of ₹10 each. This capital structure remained unchanged following the share sale.

What the Numbers Show

The open market nature of the sale indicates a standard liquidity event rather than a block deal or off-market transfer. The reduction in stake from 4.26% to 2.82% keeps Dr. Deshpande as a significant minority shareholder but reduces her voting influence proportionally. No encumbrances, pledges, or convertible securities were associated with the shares held by Dr. Deshpande before or after the transaction.

Family Care Hospitals Limited company name reported a narrowed standalone net loss of ₹42.37 lakh for the quarter ended June 30, 2026 (Q1FY27), compared to a loss of ₹69.52 lakh in the same period last year. The improvement was driven by a 190% year-on-year surge in revenue from operations, which rose to ₹5 lakh from ₹1.72 lakh in Q1FY26. Despite the revenue growth, the company continues to face significant headwinds, with statutory auditors flagging ₹38.03 crore in unutilised inventory that remains on the books pending shareholder approval for transfer.

The Board of Directors approved the unaudited financial results and the limited review report issued by Rafik and Associates, the company’s statutory auditors, on July 31, 2026. The meeting also saw the immediate appointment of Mr. Ashdullah Khan as Company Secretary and Compliance Officer. Mr. Khan is an Associate Member of the Institute of Company Secretaries of India with experience in Companies Act and Listing Regulations compliance.

Financial Performance

The company’s total income stood at ₹6.13 lakh in Q1FY27, up from ₹1.72 lakh in Q1FY26. This increase was primarily due to higher other income, which jumped to ₹1.13 lakh from nil in the corresponding prior period. However, total expenses remained high at ₹48.50 lakh, dominated by employee benefits expense of ₹9.72 lakh and depreciation and amortisation of ₹19.94 lakh. Finance costs were recorded at ₹6.44 lakh.

For the full fiscal year FY26, the company reported a net loss of ₹868.29 lakh against a total income of ₹45.02 lakh. Revenue from operations for the year was ₹20.97 lakh.

Auditor Concerns on Inventory

A critical aspect of the filing is the attention drawn by statutory auditors Rafik and Associates to Note No. 5 of the financial results. The note discloses ₹38.03 crore in discount coupon vouchers included under inventories. These vouchers have remained unutilised due to the closure of the company’s main hospital operations.

Management intends to transfer this stock to a related party; however, the requisite shareholder approval has not been received as of June 30, 2026. Consequently, the inventory continues to be carried at its book value. The auditors stated they are unable to comment on the realizable value of these vouchers or the appropriateness of carrying them at book value, citing the prolonged closure of operations and absence of a definitive revival timeframe.

What the Numbers Show

The divergence between the narrow operational revenue and the massive inventory carry-forward highlights the company’s transitional state. While the top-line revenue grew significantly on a low base, it remains negligible compared to the ₹38.03 crore in dormant assets. The reduction in net loss is largely attributable to a decrease in total expenses, particularly other expenses which swung from a negative balance in the prior quarter to a positive ₹8.38 lakh, rather than organic operational profitability. The persistence of high employee benefit costs (₹9.72 lakh) relative to minimal revenue suggests ongoing fixed cost burdens despite the closure of main hospital operations.